Table 6 Genetic results in both studied groups
From: Genetic, clinical, and biochemical aspects of patients with Alzheimer disease
|  | AD group (n = 40) | Control group (n = 40) | P value |
|---|---|---|---|
APOE-1 | Â | Â | 0.36 |
 Homogenous (CC, wild) | 36 (90%) | 34 (85%) |  |
 Heterogeneous (CT, carrier) | 4 (10%) | 6 (15%) |  |
APOE-2 | |||
 Homogenous (TT, mutant) | 40 (100%) | 40 (100%) |  |
TMEM-106 B | Â | Â | 0.04 |
 Homogenous (CC, mutant) | 3 (7.5%) | 6 (15%) |  |
 Homogenous (TT, wild) | 32 (80%) | 34 (85%) |  |
 Heterogeneous (CT, carrier) | 5 (12.5%) | 0 |  |